Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 12
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
5/23/2007
1.
Phase II-III Trial of Neocarzinostatin vs m-AMSA or ADR in Advanced Hepatocellular Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Completed
no age specified
NCI
EST-1280
2.
Phase III Chemotherapy with PALA, AMSA, VM-26, and NCS as Single Agents in Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
NCI
EST-2579
3.
Phase II Chemotherapy with Neocarzinostatin for Advanced Metastatic Urothelial Bladder Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
MSKCC-7757
4.
Phase II Chemotherapy with Neocarzinostatin for Acute Lymphocytic or Acute Nonlymphocytic Leukemia in Children
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and under
NCI
POG-7831
MDAR-319
5.
Phase II Hepatic Infusion Therapy with FUDR, MTX/TDR, NZS, ADR, BCNU, DCM for Primary or Metastatic Liver Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
under 70
DFCI-76050
6.
Phase II Chemotherapy with Neocarzinostatin for Solid Tumors and Leukemias
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
DFCI-77002
7.
Phase II Chemotherapy with Neocarzinostatin for Acute Leukemia and for Various Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI
CLB-0704
Last Modified:
9/13/2006
8.
Phase II Master Protocol and Trials with AMSA and Neocarzinostatin for non-Small Cell Lung Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
under 75
NCI
EST-1579
9.
Phase II Master Protocol with MeCCNU, MeCCNU/BCG, MeCCNU/HU/DTIC, BCG, ACT-D/HU/DTIC, CLZ, NZS, MGBG, or DBD Therapy for Metastatic Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI
EST-1675
10.
Phase II Chemotherapy with NZS for Chronic and Acute Leukemias, Lymphoma, and Liver, Renal, and Bladder Carcinomas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
MDA-DT-7534A
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute